Goldman Sachs Group Inc Pds Biotechnology Corp Call Options Transaction History
Goldman Sachs Group Inc
- $580 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PDSB
# of Institutions
76Shares Held
5.47MCall Options Held
155KPut Options Held
61.7K-
Vanguard Group Inc Valley Forge, PA1.41MShares$4.51 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$1.56 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny381KShares$1.22 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA378KShares$1.21 Million0.0% of portfolio
-
Inspirion Wealth Advisors, LLC344KShares$1.1 Million0.18% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $91.1M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...